| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO | President &CEO +1 more
2 companies
Berman Robert Andrew is a Chief Executive Officer at enVVeno Medical Corp with holdings across 2 companies. Recent SEC Form 4 filings include 11 buys and 0 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | NVNO Envveno Medical Corp | Chief Executive Officer | Buy | 12,000 | $2.55 | $30,600.00 | +5.7% | +13.0% | -87.4% | |
| Jun 27, 2022 | NVNO Envveno Medical Corp | Chief Executive Officer | Buy | 2,500 | $3.80 | $9,500.00 | +1.2% | +52.5% | -24.1% | |
| Nov 19, 2021 | NVNO Envveno Medical Corp | CEO | Buy | 2,000 | $7.43 | $14,860.00 | +34.9% | -33.7% | -19.5% | |
| Nov 16, 2021 | NVNO Envveno Medical Corp | CEO | Buy | 2,000 | $7.87 | $15,740.00 | +53.5% | -33.6% | -24.1% | |
| May 18, 2021 | NVNO Envveno Medical Corp | Chief Executive Officer | Buy | 3,000 | $5.47 | $16,410.00 | +407.6% | +24.8% | -24.2% | |
| Mar 12, 2019 | NVNO Envveno Medical Corp | Chief Executive Officer | Buy | 21,740 | $1.15 | $25,001.00 | New | - | - | |
| Jun 2, 2017 | ANIX Anixa Biosciences Inc | President &CEO | Buy | 10,000 | $0.88 | $8,797.00 | +9.7% | - | - | |
| Jul 21, 2015 | ANIX Anixa Biosciences Inc | President And CEO | Buy | 5,000 | $5.77 | $28,850.00 | +12.3% | - | - | |
| Jul 10, 2015 | ANIX Anixa Biosciences Inc | President And CEO | Buy | 200 | $4.00 | $800.00 | +0.5% | - | - | |
| Jul 7, 2015 | ANIX Anixa Biosciences Inc | President And CEO | Buy | 200 | $3.80 | $760.00 | +0.5% | - | - |